An exploratory study for development of neurophysiological indicators for prediction and evaluation of effectiveness of serotonin reuptake inhibitor fluvoxamine in patients with major depressive disorder
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 10 May 2017
At a glance
- Drugs Fluvoxamine (Primary)
- Indications Major depressive disorder
- Focus Pharmacogenomic; Therapeutic Use
- 08 Aug 2008 New trial record.